Receptor activator of NF-κB ligand-dependent expression of caveolin-1 in osteoclast precursors, and high dependency of osteoclastogenesis on exogenous lipoprotein

• Published in: Bone (New York, N.Y.) N.Y.), 2012-01, Vol.50 (1), p.226-236
• Main Authors: Hada, Naoto, Okayasu, Mari, Ito, Junta, Nakayachi, Mai, Hayashida, Chiyomi, Kaneda, Toshio, Uchida, Noritaka, Muramatsu, Takamichi, Koike, Chihiro, Masuhara, Masaaki, Sato, Takuya, Hakeda, Yoshiyuki
• Format: Article
• Language: English
• Subjects: Animals; Biological and medical sciences; Bone Resorption - metabolism; Caveolin 1 - genetics; Caveolin 1 - metabolism; Caveolin 2 - genetics; Caveolin 2 - metabolism; Fundamental and applied biological sciences. Psychology; Gene Silencing; Lipoproteins - metabolism; Male; Membrane Microdomains - metabolism; Mice; Mice, Inbred C57BL; Mice, Knockout; NFATC Transcription Factors - genetics; NFATC Transcription Factors - metabolism; Orthopedics; Osteoclasts - cytology; Osteoclasts - physiology; RANK Ligand - genetics; RANK Ligand - metabolism; Receptor Activator of Nuclear Factor-kappa B - metabolism; Signal Transduction - physiology; Stem Cells - cytology; Stem Cells - physiology; Vertebrates: anatomy and physiology, studies on body, several organs or systems
• ISSN: 8756-3282; 1873-2763
• DOI: 10.1016/j.bone.2011.10.028

Abstract Although extensive studies have done much to clarify the molecular mechanisms of osteoclastogenesis during the last ten years, there may still be unknown molecules associated with osteoclast differentiation. Thus, we used fluorescent differential display to screen for genes whose expression is induced by receptor activator of NF-κB ligand (RANKL), a crucial molecule for osteoclast formation. We identified caveolin-1 (Cav-1) as a RANKL-induced gene. Cav-1 is a major structural protein of caveolae and lipid rafts, cholesterol-enriched microdomains in the plasma membrane (PM). The RANKL-induced Cav-1 was immediately conveyed to lipid rafts. Conversely, expression of flotillin-1 (Flot-1), another scaffolding protein of lipid rafts, was reduced during osteoclastogenesis, indicating conversion of Flot-1-predominant rafts into Cav-1-enriched rafts. However, in vitro osteoclastogenesis of precursor cells from Cav-1-null mice was comparable to that of wild-type mice, while Cav-2 expression in the knockout osteoclasts was maintained. Conversely, Cav-2 gene silencing in Cav-1-null osteoclast precursors using siRNA for Cav-2 increased osteoclast formation, suggesting that the Cav-1/Cav-2 complex may act as a negative regulator for osteoclastogenesis. On the other hand, destruction of lipid rafts by removal of cholesterol from the PM by methyl-ß-cyclodextrin (MCD) treatment caused disordered signal transductions for osteoclastogenesis, such as hyperactivation of Erk1/2 and insensitivity of Akt to RANKL stimulus. The abnormal signaling was reproduced by deleting exogenous lipoproteins from the culture medium, which also resulted in reduced osteoclast formation. In addition, the deletion caused delayed expression of nuclear factor of activated T cells c1 (NFATc1), and depressed its activation in the cytosol and inhibited its translocation into nuclei. Simultaneously, the deletion reduced the level of FcRγ, a trigger protein for initiating the calcium signaling needed to activate NFATc1, and decreased Cav-1 in lipid rafts. These findings indicate that the molecular mechanisms of osteoclastogenesis are highly dependent on extracellular lipoprotein and the integrity of lipid rafts, and suggest possible involvement of cholesterol.